Patent · US Active

Method of treating renal dysfunction based on perlecan as a biomarker

US8501418B2 · kind B2 · utility

8Cited by

2References

8Claims

0Family size

Assignee

Pronata N.V. · BE

Inventors

Koen Kas · Schilde, BE
Griet Vanpoucke · Ingooigem, BE
Piet Moerman · Lexington, US

Key dates

Filing date	Aug 5, 2011
Grant date	Aug 6, 2013
Priority date	—
Expiry date	Aug 5, 2031

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY10T436/24
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

The application discloses PERLECAN as a new biomarker for renal dysfunction; methods for predicting, diagnosing, prognosticating and/or monitoring said dysfunction based on measuring said biomarker; and kits and devices for measuring said biomarker and/or performing said methods.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.